跳至主要内容
临床试验/NCT02971826
NCT02971826已完成不适用

Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2018年11月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1
试验地点
2
主要终点
number of patients with a TICI score of 2b or 3 just after the thrombectomy

研究概览

简要总结

The last marketed thrombectomy devices, named stentretriever, permit a better and faster recanalization in patient with a stroke. The REVIVETM SE is a device designed to restore the brain perfusion in patient with an intracranial artery occlusion. The REVIVETM Se device is not widely use in Europe and in France. The objective of this study is to assess the interest of using this device in the standard care of ischemic stroke in the radiology unit of the hospital Pierre Wertheimer, Lyon. The medical care will not be modified but data will be collected in order to determine whether or not this device is useful for the practice of the radiology unit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with an ischemic stroke detected by Computed Tomography (CT) or Magnetic Resonance Image (MRI)
  • Large proximal arterial occlusion : M1 segment of the Middle cerebral artery (MCA), Internal Carotid Artery (ICA) or Basilar Artery (BA)
  • Last known well (without neurological symptoms) ≤ 8 hours of treatment initiation
  • Score NIHSS ≥4
  • Eligibility on an endovascular procedure using REVIVETM SE device
  • No opposition of the patient to participate at the study

排除标准

  • Diagnostic cerebral imaging impossible
  • Distal occlusion
  • Tortuous vessel or other specificity preventing the access of device
  • Vessel diameter < 1.5 mm
  • Known hypersensibility or allergy to nitinol
  • Subjects not covered by or having the right to social security
  • Deprivation of civil rights (guardianship, safeguard justice)

研究组 & 干预措施

Thrombectomy using the REVIVETM SE device

Experimental

Thrombectomy using the REVIVETM SE device in patient with an ischemic stroke

干预措施: REVIVETM SE thrombectomy (Device)

结局指标

主要结局

number of patients with a TICI score of 2b or 3 just after the thrombectomy

时间窗: up to 2 days

The TICI score is a grading system which evaluate the degree of reperfusion as seen on arteriography

次要结局

  • Number of other procedures to treat the patient (thrombolysis, thromboaspiration, etc)(Day 0)
  • Time to obtain the appropriate recanalization (TICI 2b or 3)(At the end of the procedure - Day 0)
  • Number of the other devices use during the thrombectomy (Gidewire, catheter, etc.)(up to 2 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验